Abstract
Background
Evidence-based benchmarks have been established to assess the quality of breast cancer care, as delays in treatment correlate with poor clinical outcomes. Our aim was to identify factors influencing the timeliness of care within a rural East Texas healthcare system.
Patients and Methods
Patients diagnosed with invasive breast cancer were identified and monitored from January 2015 to October 2022. Timeliness of care was assessed retrospectively across three intervals: diagnostic imaging to biopsy, biopsy to surgical treatment, and mammogram to surgical treatment. We analyzed correlations between demographic and clinical factors influencing timely initiation of treatment in our population against recommendations from the National Consortium of Breast Centers (NCBC).
Results
A total of 278 cases were included over the 5-year study period. Nearly half met the recommended timeline from diagnostic imaging to biopsy, 13.3% from mammogram to surgical treatment, and 10.3% from biopsy to surgical treatment. A delay in the “diagnostic imaging to biopsy” interval or “biopsy to surgical treatment” interval predicted delays in the mammogram to treatment interval. Hispanics were more likely to present with stage 3 cancer and had a 4.5 times higher likelihood of mortality compared with Non-Hispanic whites.
Conclusions
Delay in one phase of care predicted delays in subsequent phases. Timeliness of treatment also influenced survival rates among Hispanic patients. Understanding factors influencing the timeliness of breast cancer treatment may guide targeted interventions in the future for patients at greater risk of care delays.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Explore related subjects
Discover the latest articles and news from researchers in related subjects, suggested using machine learning.References
Breast Cancer Facts & Figures 2019-2020. 2019. Atlanta, Ga: American Cancer Socitey, Inc.
Howlander N, Noone AM, Krapcho M, et al. SEER Cancer statistics Review, 1975-2016. 2019. based on November 2018 SEER data submission, posted to the SEER web site, April 2019. https://seer.cancer.gov/csr/1975_2016/
Castaldi M, Safadjou S, Elrafei T, McNelis J. A multidisciplinary patient navigation program improves compliance with adjuvant breast cancer therapy in a public hospital. Am J Med Qual. 2017;32(4):406–13.
Rosenberg RD, Yankaskas BC, Abraham LA, et al. Performance benchmarks for screening mammography. Radiology. 2006;241(1):55–66.
Kaufman C, Shockney L, Rabinowitz B, et al. National quality measures for breast centers (NQMBC): a robust quality tool: breast center quality measures. Ann Surg Oncol. 2010;17:377–85.
Bleicher RJ. Timing and delays in breast cancer evaluation and treatment. Ann Surgical Oncol. 2018;25:2829–38.
Richards M, Westcombe A, Love S, Littlejohns P, Ramirez A. Influence of delay on survival in patients with breast cancer: a systematic review. The Lancet. 1999;353(9159):1119–26.
Halpern M, Holden D. Disparities in timeliness of care for US Medicare patients diagnosed with cancer. Curr Oncol. 2012;19(6):e404.
Bradley CJ, Given CW, Roberts C. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst. 2002;94(7):490–6.
Hahn KM, Bondy ML, Selvan M, et al. Factors associated with advanced disease stage at diagnosis in a population-based study of patients with newly diagnosed breast cancer. Am J Epidemiol. 2007;166(9):1035–44.
Halpern MT, Ward EM, Pavluck AL, Schrag NM, Bian J, Chen AY. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis. Lancet Oncol. 2008;9(3):222–31.
Halpern MT, Chen AY, Marlow NS, Ward E. Disparities in receipt of lymph node biopsy among early-stage female breast cancer patients. Ann Surg Oncol. 2009;16:562–70.
Harlan LC, Greene AL, Clegg LX, Mooney M, Stevens JL, Brown ML. Insurance status and the use of guideline therapy in the treatment of selected cancers. J Clin Oncol. 2005;23(36):9079–88.
Qureshi M, Thacker H, Litaker D, Kippes C. Differences in breast cancer screening rates: an issue of ethnicity or socioeconomics? J Womens Health Gend Med. 2000;9(9):1025–31.
Roetzheim RG, Pal N, Tennant C, et al. Effects of health insurance and race on early detection of cancer. J Natl Cancer Inst. 1999;91(16):1409–15.
Sambamoorthi U, McAlpine DD. Racial, ethnic, socioeconomic, and access disparities in the use of preventive services among women. Prevent Med. 2003;37(5):475–84.
Ward E, Halpern M, Schrag N, et al. Association of insurance with cancer care utilization and outcomes. CA: a cancer journal for clinicians. 2008;58(1):9–31.
Texas. United States Census Bureau. https://data.census.gov/profile/Texas?g=040XX00US48
Texas Public Health Region 4/5 North. Texas Department of State Health Services. 2025. https://www.dshs.texas.gov/regional-local-health-operations/texas-public-health-region-4-5-north
QGIS Development Team. QGIS Geographic Information System. Open Source. Geospatial Foundation Project. https://qgis.org/
Dong J, Esham KS, Boehm L, et al. Timeliness of treatment initiation in newly diagnosed patients with breast cancer. Clin Breast Cancer. 2020;20(1):e27–35.
McLaughlin JM, Anderson RT, Ferketich AK, Seiber EE, Balkrishnan R, Paskett ED. Effect on survival of longer intervals between confirmed diagnosis and treatment initiation among low-income women with breast cancer. J Clin Oncol. 2012;30(36):4493–500.
Blake KD, Moss JL, Gaysynsky A, Srinivasan S, Croyle RT. Making the case for investment in rural cancer control: an analysis of rural cancer incidence, mortality, and funding trends. Cancer Epidemiol Biomark Prev. 2017;26(7):992–7.
Power EJ, Chin ML, Haq MM. Breast cancer incidence and risk reduction in the Hispanic population. Cureus. 2018;10(2)
Killelea BK, Yang VQ, Wang S-Y, et al. Racial differences in the use and outcome of neoadjuvant chemotherapy for breast cancer: results from the National cancer data base. J Clin Oncol. 2015;33(36):4267–76.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
We declare that there are no commercial conflicts of interest regarding the publication of this manuscript.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Orsi, C., Davis, T., Swindall, R. et al. Disparities in Timeliness of Breast Cancer Treatment in a Rural Setting: Breast Cancer Treatment Disparities. Ann Surg Oncol 32, 4883–4889 (2025). https://doi.org/10.1245/s10434-025-17291-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-025-17291-z